{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:29Z","timestamp":1787027789150,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Recently, sentinel lymph node biopsy (SLNB) has been introduced in the surgical staging of endometrial cancer as an alternative to systematic lymph node dissection (LND). However, the survival impact of SLNB is not yet well characterised. Methods: We performed a retrospective study of 419 patients with endometrial cancer treated with SLNB alone or with pelvic and para-aortic LND. For SLNB mapping, indocyanine green was used. Results: Median follow-up was 66 months. After exclusions, 337 patients were eligible for analysis. Of them, 150 underwent SLNB and 187 LND. During the follow-up time, 27 (24.7%) of the 150 who underwent SLNB and 54 (28.9%) of the 187 who underwent LND were diagnosed with recurrent disease (p = 0.459). The estimated 5-year disease-free survival (DFS) rate was 76.7% and 72.2% for patients in the SLNB and LND group, respectively (p = 0.419). The 5-year overall survival (OS) rates were 80.7% and 77.0% in the SLNB and LND group, respectively (p = 0.895). Survival rates were similar in both groups independent of lymph node status. Multivariable analysis confirmed that the staging approach was not associated with oncological outcome. For patients without lymph node metastases, patient outcome was worsened by advanced tumour stage and non-endometrioid tumour histology. In the group of patients with confirmed lymph node metastases, advanced tumour stage and inadequate adjuvant treatment significantly reduced DFS and OS. Conclusion: Our data suggested that SLNB did not compromise the oncological outcome of patients with endometrial cancer compared to LND.<\/jats:p>","DOI":"10.3390\/cancers15245894","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T10:04:47Z","timestamp":1702893887000},"page":"5894","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9006-4029","authenticated-orcid":false,"given":"Atanas","family":"Ignatov","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Otto-von-Guericke University, 39108 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"M\u00e9sz\u00e1ros","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Otto-von-Guericke University, 39108 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Ivros","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Otto-von-Guericke University, 39108 Magdeburg, Germany"},{"name":"Gynecologic Oncology Unit, Metropolitan Hospital, 18547 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gennari","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Otto-von-Guericke University, 39108 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Ignatov","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Otto-von-Guericke University, 39108 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00404-020-05698-w","article-title":"Comparison of survival of patients with endometrial cancer undergoing sentinel node biopsy alone or systematic lymphadenectomy","volume":"302","author":"Ignatov","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Basile","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"ASTEC Study Group, Kitchener, H., Swart, A.M., Qian, Q., Amos, C., and Parmar, M.K. (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet, 373, 125\u2013136.","DOI":"10.1016\/S0140-6736(08)61766-3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer","volume":"23","author":"Cragun","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejso.2013.01.002","article-title":"Impact of lymphadenectomy in uterine endometrioid carcinoma","volume":"39","author":"Huang","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"701758","DOI":"10.3389\/fonc.2021.701758","article-title":"Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review","volume":"11","author":"Zhai","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bogani, G., Giannini, A., Vizza, E., Di Donato, V., and Raspagliesi, F. (J. Gynecol. Oncol., 2023). Sentinel node mapping in endometrial cancer, J. Gynecol. Oncol., Online ahead of print.","DOI":"10.3802\/jgo.2024.35.e29"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","article-title":"Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): A randomised, phase 3, multicentre, non-inferiority trial","volume":"19","author":"Frumovitz","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/ijgc-2023-004555","article-title":"Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?","volume":"33","author":"Goncalves","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Terada, S., Tanaka, T., Murakami, H., Tsuchihashi, H., Toji, A., Daimon, A., Miyamoto, S., Nishie, R., Ueda, S., and Hashida, S. (2023). Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134540"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jog.12344","article-title":"Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: Current evidence","volume":"40","author":"Bogani","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ygyno.2021.01.008","article-title":"Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study","volume":"161","author":"Bogani","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1245\/s10434-023-14065-3","article-title":"Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer","volume":"30","author":"Cabrera","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ijgc-2023-004314","article-title":"Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy","volume":"33","author":"Capozzi","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Guo, Y., Sun, L., Chen, X., Wen, Q., Shao, Z., Tang, X., Shi, X., Wang, J., Zhang, Y., and Zhu, T. (2023). A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11226-1"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Khemworapong, K., Jaishuen, A., Srichaikul, P., Inthasorn, P., Viriyapak, B., Achariyapota, V., Jareemit, N., Warnnissorn, M., Hanamornroongruang, S., and Sukmee, J. (2023). The fluorescence imaging for laparoscopic and laparotomic endometrial sentinel lymph node biopsy (FILLES) trial: Siriraj gynecologic sentinel node of endometrial cancer (SiGN-En) study. J. Surg. Oncol., 1\u20137.","DOI":"10.1002\/jso.27486"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9949604","DOI":"10.1155\/2023\/9949604","article-title":"Comparing Surgical and Oncological Outcomes between Indocyanine Green (ICG) Sentinel Lymph Node Mapping with Routine Lymphadenectomy in the Surgical Staging of Early-Stage Endometrioid Endometrial Cancer","volume":"2023","author":"Koh","year":"2023","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Salman, L., Cusimano, M.C., Marchocki, Z., and Ferguson, S.E. (J. Surg. Oncol., 2023). Sentinel lymph node mapping in endometrial cancer: Current evidence and practice, J. Surg. Oncol., Online ahead of print.","DOI":"10.1002\/jso.27550"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Eriksson, A.G.Z., Davidson, B., Bjerre Trent, P., Eyjolfsdottir, B., Dahl, G.F., Wang, Y., and Staff, A.C. (2021). Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143094"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2018.08.022","article-title":"Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy","volume":"151","author":"Schlappe","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1245\/s10434-015-4612-2","article-title":"Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping","volume":"23","author":"Schiavone","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2019.10.005","article-title":"Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma","volume":"156","author":"Basaran","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2019.11.002","article-title":"Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma","volume":"156","author":"Schlappe","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2019.07.018","article-title":"Lymph node micrometastases and outcome of endometrial cancer","volume":"154","author":"Ignatov","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2009.07.016","article-title":"The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes","volume":"115","author":"Gomez","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rutten, H., Verhoef, C., van Weelden, W.J., Smits, A., Dhanis, J., Ottevanger, N., and Pijnenborg, J.M.A. (2021). Recurrent Endometrial Cancer: Local and Systemic Treatment Options. Cancers, 13.","DOI":"10.3390\/cancers13246275"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"Powell","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ijgc-2021-002703","article-title":"Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)","volume":"31","author":"Emons","year":"2021","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/24\/5894\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:01Z","timestamp":1760132461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/24\/5894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":33,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["cancers15245894"],"URL":"https:\/\/doi.org\/10.3390\/cancers15245894","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}